DEVELOPMENT OF NON-INVASIVE INNOVATIVE DIAGNOSTIC DIAGNOSTIC FOR PRECLINICAL DIAGNOSIS OF LUNG CANCER BY A COMBINATION OF 2 BIOMARKER BIOSENSOR (Q2023571): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claims)
(‎Changed an Item: The budget was changed)
Property / budget
 
70,791.29 Euro
Amount70,791.29 Euro
UnitEuro
Property / budget: 70,791.29 Euro / rank
 
Normal rank
Property / EU contribution
 
0.0 Euro
Amount0.0 Euro
UnitEuro
Property / EU contribution: 0.0 Euro / rank
 
Normal rank
Property / co-financing rate
 
0.0 percent
Amount0.0 percent
Unitpercent
Property / co-financing rate: 0.0 percent / rank
 
Normal rank

Revision as of 04:00, 9 February 2022

Project Q2023571 in Italy
Language Label Description Also known as
English
DEVELOPMENT OF NON-INVASIVE INNOVATIVE DIAGNOSTIC DIAGNOSTIC FOR PRECLINICAL DIAGNOSIS OF LUNG CANCER BY A COMBINATION OF 2 BIOMARKER BIOSENSOR
Project Q2023571 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    0.0 Euro
    0 references
    budget
    70,791.29 Euro
    0 references
    co-financing rate
    0.0 percent
    0 references
    start time
    17 November 2017
    0 references
    expected end time
    6 August 2019
    0 references
    beneficiary name (string)
    IMMUNEPHARMA SRL
    0 references
    beneficiary
    Q278350
    0 references
    programme
    Campania - ERDF
    0 references
    coordinate location

    40°46'22.12"N, 14°47'57.98"E
    0 references
    summary
    IL DEVICE CHE SI INTENDE SVILUPPARE NEL CORSO DEL PRESENTE PROGETTO SARà COSTITUITO DA UN DISPOSITIVOELETTRONICO, BASATO SU UN NANO-BIOSENSORE E UN SISTEMA AUTOMATICO DI LETTURA DEI LIVELLI DI BIOMARKERCON AZIONE RIVELATRICE DELL'INSORGERE DEL CANCRO POLMONARE.. ATTRAVERSO IL DEVICE 'PORTATILE' DI PICCOLEDIMENSIONI LE PERSONE POTRANNO EFFETTUARE, CON IL SEMPLICE AUSILIO DEL MEDICO DI BASE O DEL FARMACISTA,UN TEST DI INDIVIDUAZIONE DEL BIOMARCATORE PREDITTIVO E PROGNOSTICO, OVVERO INDIVIDUARE UNACARATTERISTICA DI BASE CHE DISTINGUE I PAZIENTI PER GRADO DI RISCHIO DI INSORGENZA DELLA MALATTIA O INBASE ALLA PROGRESSIONE DELLA MALATTIA. I RISULTATI DEL TEST DANNO LA POSSIBILITà DI INTERVENIREPRECOCEMENTE NEL CASO DI INSORGENZA DELLA MALATTIA. TALE DEVICE ELETTRONICO SARà BREVETTATO A PARTIREDAL BREVETTO 'MADRE'. (Italian)
    0 references
    THE DEVICE WHICH IS INTENDED TO BE DEVELOPED IN THE COURSE OF THIS PROJECT WILL BE MADE UP OF A VETERINARY DEVICE, BASED ON A NANO-BIOSENSORE, AND AN AUTOMATIC READING SYSTEM OF THE LEVELS OF BIOMEARKERN, INDICATING THE OCCURRENCE OF LUNG CANCER. BY MEANS OF THE ‘PORTABLE DEVICE’ OF PICCOELDIMENSIONS, INDIVIDUALS WILL BE ABLE TO CARRY OUT, WITH THE ASSISTANCE OF THE BASIC DOCTOR OR PHARMACIST, A PREDICTION TEST FOR PREDICTIVE AND PROGNOSTIC BIOMARKER BIOMARKER DETECTION, OR TO IDENTIFY UNACATTERISTICS THAT DISTINGUISHES PATIENTS BY THE DEGREE OF RISK OF DISEASE OCCURRENCE OR DISEASE PROGRESSION. THE RESULTS OF THE TEST GIVE THE POSSIBILITY OF HIS OR HER INVOLVEMENT IN THE EVENT OF AN OUTBREAK OF THE DISEASE. THIS ELECTRONIC DEVICE WILL BE PATENTED BY THE ‘MOTHER’ PATENT. (English)
    0 references
    THE DEVICE WHICH IS INTENDED TO BE DEVELOPED IN THE COURSE OF THIS PROJECT WILL BE MADE UP OF A VETERINARY DEVICE, BASED ON A NANO-BIOSENSORE, AND AN AUTOMATIC READING SYSTEM OF THE LEVELS OF BIOMEARKERN, INDICATING THE OCCURRENCE OF LUNG CANCER. BY MEANS OF THE ‘PORTABLE DEVICE’ OF PICCOELDIMENSIONS, INDIVIDUALS WILL BE ABLE TO CARRY OUT, WITH THE ASSISTANCE OF THE BASIC DOCTOR OR PHARMACIST, A PREDICTION TEST FOR PREDICTIVE AND PROGNOSTIC BIOMARKER BIOMARKER DETECTION, OR TO IDENTIFY UNACATTERISTICS THAT DISTINGUISHES PATIENTS BY THE DEGREE OF RISK OF DISEASE OCCURRENCE OR DISEASE PROGRESSION. THE RESULTS OF THE TEST GIVE THE POSSIBILITY OF HIS OR HER INVOLVEMENT IN THE EVENT OF AN OUTBREAK OF THE DISEASE. THIS ELECTRONIC DEVICE WILL BE PATENTED BY THE ‘MOTHER’ PATENT. (English)
    0 references
    L’APPAREIL QUI SERA DÉVELOPPÉ AU COURS DE CE PROJET CONSISTERA EN UN DISPOSITIVOELETTRONICO, BASÉ SUR UN NANO-BIOCAPTEUR ET UN SYSTÈME AUTOMATIQUE DE LECTURE DES NIVEAUX BIOMARKERCON RÉVÉLANT L’APPARITION D’UN CANCER DU POUMON. GRÂCE AU DISPOSITIF «PORTABLE» DE PETITE TAILLE, LES GENS POURRONT RÉALISER, AVEC L’AIDE SIMPLE DU MÉDECIN DE BASE OU DU PHARMACIEN, UN TEST DE DÉTECTION DU BIOMARQUEUR PRÉDICTIF ET PRONOSTIQUE, OU IDENTIFIER UNE CARACTÉRISTIQUE DE BASE QUI DISTINGUE LES PATIENTS PAR DEGRÉ DE RISQUE D’APPARITION DE LA MALADIE OU EN FONCTION DE LA PROGRESSION DE LA MALADIE. LES RÉSULTATS DU TEST DONNENT LA POSSIBILITÉ D’INTERVENIREPRECECEMENT EN CAS D’APPARITION DE LA MALADIE. CE DISPOSITIF ÉLECTRONIQUE SERA BREVETÉ PAR LE BREVET «MÈRE». (French)
    point in time
    14 December 2021
    0 references
    HET APPARAAT DAT TIJDENS DIT PROJECT ZAL WORDEN ONTWIKKELD, ZAL BESTAAN UIT EEN DISPOSITIVOELETTRONICO, GEBASEERD OP EEN NANO-BIOSENSOR EN EEN AUTOMATISCH SYSTEEM VOOR HET LEZEN VAN BIOMARKERCON-NIVEAUS DIE HET OPTREDEN VAN LONGKANKER ONTHULLEN. VIA HET „DRAAGBARE” APPARAAT VAN KLEINE AFMETINGEN KUNNEN MENSEN MET DE EENVOUDIGE HULP VAN DE BASISARTS OF APOTHEKER EEN TEST UITVOEREN VOOR DE DETECTIE VAN DE VOORSPELLENDE EN PROGNOSTISCHE BIOMARKER, OF EEN BASISKENMERK IDENTIFICEREN DAT PATIËNTEN ONDERSCHEIDT DOOR DE MATE VAN RISICO OP HET ONTSTAAN VAN DE ZIEKTE OF OP BASIS VAN DE PROGRESSIE VAN DE ZIEKTE. DE RESULTATEN VAN DE TEST GEVEN DE MOGELIJKHEID VAN INTERVENIREPRECECEMENT IN HET GEVAL VAN EEN BEGIN VAN DE ZIEKTE. DIT ELEKTRONISCHE APPARAAT WORDT GEPATENTEERD OP BASIS VAN HET „MOEDER”-OCTROOI. (Dutch)
    point in time
    23 December 2021
    0 references
    DAS IM RAHMEN DIESES PROJEKTS ENTWICKELTE GERÄT BESTEHT AUS EINEM DISPOSITIVOELETTRONICO, DER AUF EINEM NANO-BIOSENSOR UND EINEM AUTOMATISCHEN SYSTEM ZUM ABLESEN VON BIOMARKERCON-SPIEGELN BASIERT, DIE DAS AUFTRETEN VON LUNGENKREBS AUFZEIGEN. DURCH DAS „TRAGBARE“ GERÄT IN KLEINEN GRÖSSEN KÖNNEN DIE MENSCHEN MIT EINFACHER HILFE DES GRUNDARZTES ODER APOTHEKERS EINEN TEST ZUM NACHWEIS DES PRÄDIKTIVEN UND PROGNOSTISCHEN BIOMARKERS DURCHFÜHREN ODER EIN GRUNDLEGENDES MERKMAL ERKENNEN, DAS DIE PATIENTEN DURCH DAS RISIKO DES AUFTRETENS DER KRANKHEIT ODER DURCH DAS FORTSCHREITEN DER KRANKHEIT UNTERSCHEIDET. DIE ERGEBNISSE DES TESTS BIETEN DIE MÖGLICHKEIT EINER INTERVENIREPRECECEMENT IM FALLE EINES AUSBRUCHS DER SEUCHE. DIESES ELEKTRONISCHE GERÄT WIRD VOM PATENT „MUTTER“ PATENTIERT. (German)
    point in time
    24 December 2021
    0 references
    EL DISPOSITIVO QUE SE DESARROLLARÁ DURANTE ESTE PROYECTO CONSISTIRÁ EN UN DISPOSITIVOELETTRONICO, BASADO EN UN NANO-BIOSENSOR Y UN SISTEMA AUTOMÁTICO DE LECTURA DE LOS NIVELES DE BIOMARKERCON QUE REVELAN LA OCURRENCIA DE CÁNCER DE PULMÓN. A TRAVÉS DEL DISPOSITIVO PORTÁTIL DE PEQUEÑO TAMAÑO, LAS PERSONAS PODRÁN REALIZAR, CON LA SIMPLE AYUDA DEL MÉDICO O FARMACÉUTICO DE BASE, UNA PRUEBA PARA LA DETECCIÓN DEL BIOMARCADOR PREDICTIVO Y PRONÓSTICO, O IDENTIFICAR UNA CARACTERÍSTICA BÁSICA QUE DISTINGA A LOS PACIENTES POR GRADO DE RIESGO DE APARICIÓN DE LA ENFERMEDAD O EN FUNCIÓN DE LA PROGRESIÓN DE LA ENFERMEDAD. LOS RESULTADOS DE LA PRUEBA DAN LA POSIBILIDAD DE INTERVENIREPRECEMENTO EN CASO DE APARICIÓN DE LA ENFERMEDAD. ESTE DISPOSITIVO ELECTRÓNICO SE PATENTARÁ A PARTIR DE LA PATENTE «MADRE». (Spanish)
    point in time
    24 January 2022
    0 references

    Identifiers

    Italian Unique Project Code
    B42C18000060007
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2023571&oldid=27441377"